Importantly, we found that 18% (nine of 49) pT1 stage RCC tumors vs. 57% (18 of 31) of pT2‐3 stage RCC tumors had a stronger ERβ staining (P = 0.0005) (Fig. 1A). The gene discussed is ESR2; the disease is renal cell carcinoma.